| „Back to the roots-from Phenotype to Genotype in Monozygotic Twins discordant for Multiple Sclerosis “(P1-1. Virtual) C Janoschka, M Herrera-Rivero, L Gerdes, K Koch, H Wiendl, R Hohlfeld, ... Neurology 98 (18 Supplement), 2022 | | 2022 |
| „Chronic cerebrospinal venous insufficiency” and multiple sclerosis: Critical analysis and first observation in an unselected cohort of MS patients C Krogias, A Schröder, H Wiendl, R Hohlfeld, R Gold Der Nervenarzt 81, 740-746, 2010 | 82 | 2010 |
| (DMT02) Yearly Efficacy and Safety Outcomes Over 4 Years After Last Alemtuzumab Course in Pooled CAREMS I and II Patients by Number of Additional Courses Received Through Year 9. R Berkovich, R Alroughani, AD Bass, AL Boster, G Comi, HJ Kim, ... International Journal of MS Care 22, 2020 | | 2020 |
| (DMT03) Efficacy and Safety of Ofatumumab Versus Teriflunomide in Patients with Relapsing Multiple Sclerosis: Phase 3 ASCLEPIOS I and II Trials. AH Cross, L Kappos, A Bar-Or, JA Cohen, G Comi, J Correale, PK Coyle, ... International Journal of MS Care 22, 2020 | | 2020 |
| (DXT02) Early Effect of Ofatumumab on B-Cell Counts and Magnetic Resonance Imaging Activity in Relapsing Multiple Sclerosis Patients: Results from the APLIOS Study. A Bar-Or, EJ Fox, A Goodyear, I Ludwig, M Bagger, DA Haering, ... International Journal of MS Care 22, 2020 | | 2020 |
| (DXT65) Longitudinal Disability Follow-up in Patients with 6-Month Confirmed Disability Improvement or Worsening in the CARE-MS and Extension Studies. SF Hunter, DP Baker, M Ozog, EM Poole, L Chung, P Vermersch, ... International Journal of MS Care 22, 2020 | | 2020 |
| [18F]DPA-714-PET-MRI reveals pronounced innate immunity in human anti-LGI1 and anti-CASPR2 limbic encephalitis W Roll, J Bauer, A Dik, C Mueller, P Backhaus, S Räuber, B Zinnhardt, ... Journal of Neurology, 1-7, 2024 | | 2024 |
| 023 Relapse outcomes with natalizumab Q4W vs switch to Q6W H Butzkueven, L Kappos, T Spelman, M Trojano, H Wiendl, R Su, R Hyde, ... Journal of Neurology, Neurosurgery & Psychiatry 93 (6), A20-A21, 2022 | | 2022 |
| 054 Disability improvement is observed in each functional system in alemtuzumab-treated patients with active RRMS: results from CARE-MS II extension RAL Macdonell, RA Aburashed, R Alroughani, D Dive, G Izquierdo, ... Journal of Neurology, Neurosurgery and Psychiatry 89 (6), A22, 2018 | | 2018 |
| 085 Clinical outcomes were better for relapsing-remitting multiple sclerosis (RRMS) patients who remained on natalizumab compared to those who switched to oral or injectable … H Butzkueven, L Kappos, T Spelman, M Trojano, H Wiendl, Q Dong, ... Journal of Neurology, Neurosurgery & Psychiatry 89 (6), A34-A34, 2018 | | 2018 |
| 10 year follow-up of the European study of Interferon-beta-1b (EUSPMS) in secondary progressive multiple sclerosis-Interim report J Kuhle, K Gugleta, M Hardmeier, M Ecsedi, M Laaksonen, M D'Hooghe, ... MULTIPLE SCLEROSIS 12, S186-S186, 2006 | | 2006 |
| 116 Serum immunoglobulin levels and infection risk in Phase 3 ofatumumab trials in relapsing multiple sclerosis H Wiendl, J de Seze, A Bar-Or, J Correale, A Cross, L Kappos, K Selmaj, ... Journal of Neurology, Neurosurgery & Psychiatry 93 (6), A137-A137, 2022 | | 2022 |
| 12/15-lipoxygenase mediates GC-induced anti-inflammatory mechanisms in monocytes Y Kusche, L Klotz, H Wiendl, J Roth, K Barczyk IMMUNOLOGY 137, 262-262, 2012 | | 2012 |
| 12/15-LIPOXYGENASE MEDIATES GC-INDUCED ANTI-INFLAMMATORY MECHANISMS IN MONOCYTES Y Fleischer, K Barczyk, L Klotz, H Wiendl, J Roth ANNALS OF THE RHEUMATIC DISEASES 71, 72-72, 2012 | | 2012 |
| 12/15-lipoxygenase mediates glucocorticoid-induced anti-inflammatory mechanisms in monocytes Y Kusche, L Klotz, H Wiendl, J Roth, K Barczyk-Kahlert EUROPEAN JOURNAL OF CLINICAL INVESTIGATION 44, 24-25, 2014 | | 2014 |
| 14 Cytokine-Based H Wiendl, R Hohlfeld, III Interferons Cytokines and the CNS, 327, 2005 | | 2005 |
| 14‐3‐3 Proteins regulate K2P5.1 surface expression on T lymphocytes J Fernández‐Orth, P Ehling, T Ruck, S Pankratz, MS Hofmann, ... Traffic 18 (1), 29-43, 2017 | 25 | 2017 |
| 144 Long-term efficacy of ofatumumab in patients with relapsing multiple sclerosis S Hauser, E Fox, A Aungst, W Su, R Zielman, AD Gupta, D Stoneman, ... Journal of Neurology, Neurosurgery & Psychiatry 93 (9), e2, 2022 | 14* | 2022 |
| 199 Changes in natalizumab exposure and PML incidence over time G Giovannoni, L Kappos, J Berger, G Cutter, R Fox, H Wiendl, I Chang, ... Journal of Neurology, Neurosurgery and Psychiatry 90 (12), e50, 2019 | | 2019 |
| 212 DEFICIENCY OF THE NEGATIVE IMMUNE REGULATOR B7H1 ENHANCES INFLAMMATION AND NEUROPATHIC PAIN AFTER CHRONIC CONSTRICTION INJURY OF MOUSE SCIATIC NERVE N Üçeyler, S Ortler, S Meuth, G Stoll, H Wiendl, C Kleinschnitz, C Sommer European Journal of Pain Supplements 4 (S1), 62-62, 2010 | | 2010 |
Ludwig KapposUniversity Hospital Basel在 uhbs.ch 的电子邮件经过验证
